COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

Version 2 2024-06-03, 22:23

Version 1 2022-11-23, 04:36

conference contribution

posted on 2024-06-03, 22:23 authored by Lan GaoLan Gao, SC Li

COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

History

Volume

15

Pagination

A663-A663

Publisher DOI

https://doi.org/10.1016/j.jval.2012.08.358

Link to full text

https://doi.org/10.1016/j.jval.2012.08.358

ISSN

1098-3015

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000312411102192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Title of proceedings

VALUE IN HEALTH

Issue

7

Publisher

ELSEVIER SCIENCE INC

Usage metrics

Categories

Keywords

Social Sciences Science & Technology Life Sciences & Biomedicine Economics Health Care Sciences & Services Health Policy & Services Business & Economics

Licence

All Rights Reserved

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC